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The vertebrate Dlx genes, generally organized as tail-to-tail bigene clusters, are expressed in the branchial arch epithelium and
mesenchyme with nested proximodistal expression implicating a code that underlies the fates of jaws. Little is known of the regulatory
architecture that is responsible for Dlx gene expression in developing arches. We have identified two distinct cis-acting regulatory sequences,
I12a and I56i, in the intergenic regions of the Dlx1/2 and Dlx5/6 clusters that act as enhancers in the arch mesenchyme. LacZ transgene
expression containing I12a is restricted to a subset of Dlx-expressing ectomesenchyme in the first arch. The I56i enhancer is active in a
broader domain in the first arch mesenchyme. Expression of transgenes containing either the I12a or the I56i enhancers is dependent on the
presence of epithelium between the onset of their expression at E9–10 until independence at E11. Both enhancers positively respond to
FGF8 and FGF9; however, the responses of the reporter transgenes were limited to their normal domain of expression. BMP4 had a negative
effect on expression of both transgenes and counteracted the effects of FGF8. Furthermore, bosentan, a pharmacological inhibitor of
Endothelin-1 signaling caused a loss of I56i-lacZ expression in the most distal aspects of the expression domain, corresponding to the area of
Dlx-6 expression previously shown to be under the control of Endothelin-1. Thus, the combinatorial branchial arch expression of Dlx genes is
achieved through interactions between signaling pathways and intrinsic cellular factors. I56i drives the entire expression of Dlx5/6 in the first
arch and contains necessary sequences for regulation by at least three separate pathways, whereas I12a only replicates a small domain of
endogenous expression, regulated in part by BMP-4 and FGF-8.
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Introduction domain. The molecular basis for how the tissues areThe first branchial arch, which gives rise to the mandible
and maxilla, is made of proliferating neural crest-derived
ectomesenchyme covered by an epithelial layer that differ-
entiates into a variety of different tissue types. The arch is
considered to be regionalized into a large maxillomandibu-
lar proximal domain with a smaller distal mandibular0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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2 These authors contributed equally to the work.organized relies on epitheliomesenchymal interactions,
which involve many different factors in a dynamic spatio-
temporal cascade (Trumpp et al., 1999). Initial patterning of
the mandibular arch involves epithelial signaling factors that
include FGF8 (Tucker et al., 1999), FGF9 (Colvin et al.,
1999; Kettunen and Thesleff, 1998), BMP4 (Tucker et al.,
1998a,b), and endothelin-1 (Thomas et al., 1998) as well as
regionalized expression of homeobox genes, such as Dlx,
Msx, Barx1, Lhx, Pax9, and Gsc (reviewed in Francis-West
et al., 1998). Rostrocaudal polarity of the mandibular arch is
induced by FGF8 signaling in the oral epithelium (Tucker et
al., 1999). Recent work by Depew et al. (2002) and
Beverdam et al. (2002) suggest that Dlx family members
are necessary for specification of the proximodistal axis. In
the mouse, the Dlx1 and Dlx2 genes are similarly expressed
in the epithelial and mesenchymal cells of both the man-
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(Qiu et al., 1997b). The Dlx5 and Dlx6 genes are expressed
in a nested manner in the mandibular domain, but not the
maxillary domain of the first arch before initiation of tooth
development. Mouse embryos that are homozygous for a
mutation that inactivates both Dlx1 and Dlx2 exhibit a loss
or malformation of proximal arch features typified by the
loss of maxillary molars yet retain all other teeth (Qiu et al.,
1997a). The loss of function of both Dlx5 and Dlx6 results
in a mirror duplication of maxillary features in the mandible,
indicating that maxillary expressed Dlx1/2 genes pattern
proximal tissues (Qiu et al., 1997b) while Dlx5/6 are
required for distal tissues (Beverdam et al., 2002; Depew
et al., 2002).
To further understand Dlx gene function within arch
patterning, it is necessary to examine the mechanisms
responsible for their spatial expression and for their re-
sponse to epidermal regulatory cues. The concerted regula-
tion of Dlx genes may be related to their genomic
organization. The Dlx1 and Dlx2 genes are linked on mouse
chromosome 2 (McGuinness et al., 1996), while the Dlx5
and Dlx6 genes are linked on chromosome 7 (Simeone et
al., 1992). This genomic organization is also found for a
third Dlx bigene cluster, Dlx3/4 (formerly Dlx3/7) (Ellies et
al., 1997; Stock et al., 1996; Sumiyama et al., 2002) and
orthologous bigene clusters have been found in human and
in teleost fish (Ellies et al., 1997; Ghanem et al., 2003;
Simeone et al., 1994; Stock et al., 1996). The genomic
organization of vertebrate Dlx genes may be related to their
overlapping expression in several tissues through enhancer
sharing (Ellies et al., 1997; Zerucha et al., 2000). The short
(about 3–15 kb) intergenic region of Dlx bigene clusters
contains some of the cis-acting sequences that are involved
in Dlx gene regulation (Ghanem et al., 2003; Sumiyama et
al., 2002; Zerucha et al., 2000). Thus, our previous work has
shown that evolutionary conserved enhancer elements with-
in the intergenic region of Dlx5/6 are capable of inducing
reporter gene expression in the forebrain that replicates
endogenous patterns (Zerucha et al., 2000). A distinct
enhancer with forebrain activity was recently found in the
Dlx1/2 intergenic region (Ghanem et al., 2003), suggesting
that enhancers unrelated in sequence can target Dlx expres-
sion with overlapping patterns.
One of the forebrain enhancers in the Dlx5/6 intergenic
region, I56i, is also able to target expression of a reporter
transgene to the first branchial arch (Zerucha et al., 2000).
Interspecies sequence comparisons of the Dlx1/2 loci has
further revealed a highly conserved sequence of about 550
bp, I12a, which shows enhancer activity in the first bran-
chial arch of transgenic mice, but not in the forebrain
(Ghanem et al., 2003). Here we examine the spatial and
temporal activity of the I56i and I12a enhancers and
determine the effects of epithelial factors on the expression
of lacZ reporter constructs containing either I56i or I12a in
the mandibular mesenchyme of transgenic mice. The two
sequences are unrelated, showing no evidence of conserva-tion, but are both transiently dependent on signals from the
epithelium. Both enhancers are similarly regulated by FGF-
8 and BMP-4, but only I56I is regulated ET-1.Materials and methods
Construction of lacZ reporter constructs transgenic mouse
production
Constructs 2, 3, and 5 (Fig. 1) were made in the p1229 or
p1230 vectors (Yee and Rigby, 1993) where the lacZ gene is
placed under the control of a minimal human h-globin
promoter. Construct 2 (Fig. 1A) was made by successive
subcloning resulting in the introduction of a 1.9-kb fragment
of the mouse Dlx1/Dlx2 locus delineated by XbaI and
EcoR1 restriction sites and containing the conserved I12a
sequence. The conserved I12a sequence (Ghanem et al.,
2003) and surrounding nucleotides (total size: 713 bp) was
introduced into the reporter vector (construct 3) after PCR
amplification with the primers: CCAAGCTTCCTATGCT-
GAGAACAGAG and CCAAGCTTCGTCAATTTCCT-
CATTTGC, followed by direct subcloning into the HindIII
site of the p1230 reporter vector.
A 1.6 kb XhoI–XhoI zebrafish fragment (zI12a 1.6 kb;
construct 5), containing the conserved I12a sequence was
directly subcloned into the reporter vector.
A reporter transgene construct containing the entire
mouse Dlx1/Dlx2 intergenic region (mI12a 13.5; Fig. 1A,
construct 1), was made by first inserting a 13.5 kb BamHI–
BamHI fragment that includes the Dlx1/2 intergenic region
into a pBluescript plasmid. The h-globin promoter-lacZ
cassette from the p1229 vector was then amplified by
PCR and inserted downstream of the mouse intergenic
fragment.
Construct 4 was made by introducing the 1.9-kb XbaI–
EcoRI fragment identical to that used in construct 2 into the
reporter transgene plasmid described by Thomas et al.
(2000), which also contains a 3.8-kb fragment of the 5V-
flanking region of Dlx2.
For the production of transgenic mice, the transgene was
excised from the plasmid construct and injected at a con-
centration of 5 ng/Al in eggs from FVB/n crosses using
standard procedures (Hogan et al., 1986). Transgenes were
analyzed in either founder embryos or from established
transgenic lines. Presence of the transgene was assayed by
PCR on DNA prepared from embryonic tissues as described
previously (Zerucha et al., 2000). Production of lines of
transgenic mice containing the mouse I56i enhancer has
been previously described (Zerucha et al., 2000).
b-galactosidase staining
Embryos from hemizygous mouse embryos (transgenic
FBV males  CD1 females) were harvested at various
embryonic stages and assayed for h-gal activity by staining
Fig. 1. The mouse and zebrafish Dlx1/2 loci and lacZ transgene constructs. Schematic representation of the mouse and zebrafish Dlx1/Dlx2 loci with Dlx1 to
the left. Exons are portrayed as orange blocks and numbered in Roman numerals, gene transcripts including untranslated regions (UTR) of Dlx1 and Dlx2 are
depicted as convergent green arrows. The position of the I12a and I12b cis-acting regulatory sequences are indicated by red and blue blocks, respectively.
Restriction sites are labeled as the following: B, BamHI; E, EcoRI; H, HindIII; Xb, XbaI; X, XhoI. The lacZ constructs with the h-globin minimal promoter
(grey box) containing I12a used for the production of transgenic mouse lines of are numbered and schematized underneath.
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Noon on the day a vaginal plug was detected is considered
as E0.5. Embryos were staged precisely based on morpho-
logical criteria (Kaufman, 1995). X-Gal stained embryos
were cryo-sectioned (thickness: 16 Am) and counterstained
with eosin.
In situ hybridization
Whole-mount digoxigenin (DIG) in situ hybridization
was performed as previously described except that mouse
embryos were incubated in 6% hydrogen peroxide for 45
min to enhance signal visibility (Wilkinson, 1992). Anti-
sense probes were generated from mouse cDNA clones.
Dlx2 was linearized with HindIII and an antisense riboprobe
was transcribed with T3 Pol and DIG-UTP (Roche). In situ
hybridization after X-Gal staining was performed as de-
scribed by Tajbakhsh and Houzelstein (1995).
Culture and bead implantation
Cultures were carried out using tissues from hemizygous
mouse embryos (transgenic FBV  CD1) aged between
E9.5 and E11.5. Mandibular arches were dissected out in D-
MEM culture media (Invitrogen). When separation of epi-
thelium and mesenchyme was required, the explants wereincubated in Dispase (Invitrogen) in calcium and magne-
sium-free phosphate-buffered saline (PBS) at 2 units/ml for
7–10 min at 37jC, depending on age and size. After
incubation, the tissues were washed in D-MEM with 10%
fetal calf serum (FCS), and the epithelium was dissected
using micropincettes. The mesenchyme was placed on
membrane filters (0.1-Am pore size, Millipore) supported
by stainless steel grids and beads were placed as required.
For FGF8 and FGF9, heparin acrylic beads (Sigma) were
used. These were washed several times in PBS, then
incubated overnight at 4jC in FGF8b or FGF9 (R&D
Systems) at a concentration of 1 Ag/ml. For BMP4 and
noggin, Affi-Gel-blue beads (Bio Rad) were used. The
beads were washed and dried, then soaked in a 100 ng/ml
BMP4 (R&D Systems) or 1 Ag/ml Noggin (R&D Systems)
solution for 1 h at 37jC. Bovine serum albumin (BSA)
control beads (both Affi-Gel-blue and heparin acrylic) were
made in a similar manner. The protein-soaked beads were
stored for up to 2 weeks at 4jC. Endothelin-1 inhibition was
accomplished by culturing dissected arches in medium
containing 1 mg/ml of bosentan (Actelion Pharmaceuticals
Ltd).
The explants were cultured for 18–24 h in D-MEM with
10% FCS at 37jC in a humidified atmosphere of 95% air
and 5% CO2. All solutions used contained penicillin and
streptomycin at 20 IU/ml. After the period of culture, the
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or X-Gal staining.Results
The Dlx1/2 intergenic region targets reporter transgene
expression to the branchial arches, forebrain, and limbs
To determine the presence of cis-acting regulatory
sequences in the Dlx1/2 intergenic region, a 13.5-kb frag-
ment that includes the mouse intergenic region separating
the 3V exons of the linked genes was cloned into a lacZFig. 2. Enhancer activity of the I12a cis-acting regulatory sequence. (A) Whole-m
13.5-kb lacZ reporter transgene containing the entire I12 intergenic region (constr
forebrain, mandibular (Mn) and hyoid (Hy) branchial arches, and the limb bud
mandibular arch, viewed from the oral surface, from an embryo similar to that sh
Orientation is indicated by p (proximal, dorsal) and d (distal, ventral). (B) E9.5
maxilla (Mx) and mandible. (B, inset) E10.5, bifurcation of maxilla and mandibu
Whole-mount in situ of E9.5 Dlx2 expression in the maxilla and mandible and in th
in the mandible (arrowhead) and hyoid. (E) E10.5 dissected mandible showing bi
galactosidase activity (light blue) and Dlx2 mRNA expression (purple). Transg
endogenous mesenchymal expression domain. P: proximal. (G, H) E10.5, fron
transgenic mice containing the zebrafish I12a1.6-LacZ reporter construct (constru
(I; 50) frontal section at E10.5 shows h-galactosidase activity targeted to the rostr
ectomesenchyme (EM) and absent in the oral epithelium (OE) magnification: 400
obtained with two additional lines produced with the same transgene. (K, L) E11.5 p
5V flanking Dlx2-LacZ reporter construct (construct 4) (Thomas et al., 2000). Tran
(star) and in the restricted bilateral mesenchymal domains shown in the dissected
orientated distal to the top and oral side facing.reporter gene construct containing a human h-globin min-
imal promoter (mI12a13.5; Fig. 1A, construct 1). Transgene
expression was examined in two primary embryos and five
lines of transgenic animals at E11.5 (Fig. 2A), a time point
chosen because it gives a general overview of Dlx expres-
sion, although other time points were also examined (data
not shown). Transgenic animals carrying the above con-
struct showed strong and reproducible expression in several
domains of endogenous Dlx1/2 expression. These included
the telencephalic and diencephalic domains of expression in
the forebrain, the frontonasal prominence, the apical ecto-
dermal ridge (AER) of developing limb buds, and the
genital tubercle (Fig. 2A and data not shown). At this time,ount h-galactosidase staining of an E11.5 mouse transgenic embryo with a
uct 1) shows expression in diencephalon (Di) and telencephalon (Tl) of the
apical ectodermal ridge (AER; arrowheads). (A, inset) E11.5 dissected
own in A exhibits mesenchymal lacZ expression in two bilateral domains.
embryo (line 1486; construct 2) shows lacZ expression in the prospective
lar I12a-lacZ expression shown in the first branchial arch (line 1486). (C)
e hyoid arch. (D) E11.5 primary embryo (construct 3) with lacZ expression
lateral transgene expression in comparison to a mandible (F) stained for h-
ene activity (arrowhead) is restricted to the most distal (d) aspect of the
tal views reveal conservation of arch mesenchymal expression pattern in
ct 5) in comparison to mouse I12a1.9-LacZ (construct 2) enhancer activity.
al half of the arch (arrowheads). (J) Transgene expression is restricted to the
. Embryos are from transgenic line 1483 (construct 2). Similar results were
rimary embryo exhibiting I12a-lacZ expression in combination with a 3.8-kb
sgene expression is observed in the maxilla and mandibular oral epithelium
mandible (L, arrowheads). (K) Frontal view. All dissected mandibles are
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mesenchymal cells in the mandibular portion of the first
arch and in the hyoid arch (Fig. 2A and inset). Expression
intensity varied between lines, likely due to the copy
number and insertional site of the transgene into the
genome. None of the primary transgenics or transgenic lines
reproduced the entire pattern of Dlx expression in the
mesenchyme of the first branchial arch. None expressed
lacZ in the epithelium of the arches, consistent with prior
identification of an arch epithelium enhancer upstream of
Dlx2 (Thomas et al., 2000).
Activity of the I12a enhancer in mesenchymal cells of the
mandibular component
To investigate the genetic elements within the intergenic
region responsible for targeting gene expression, we previ-
ously carried out interspecies comparisons of the Dlx1/Dlx2
intergenic sequence from human, mouse, zebrafish, and two
species of pufferfish (Ghanem et al., 2003). The similarity
between the five species was limited to domains of high
sequence conservation, I12a and I12b. In transgenic ani-
mals, I12a targeted expression of reporter constructs to the
branchial arches with patterns that were identical to those
obtained containing the entire intergenic region while I12b
showed enhancer activity only in the forebrain (Ghanem et
al., 2003). Transgenic mice were made with a lacZ reporter
construct containing a 1.9 kb XbaI–EcoRI fragment (Fig.
1) from the mouse locus encompassing I12a (Fig. 1A,
construct 2).
We obtained five lines of transgenic mice with the I12a-
containing construct 2 and used three of them to examine in
detail the spatial and temporal activity of the I12a enhancer.
One line showed lacZ expression in a group of ectomesen-
chymal cells in the first arch at E9.5, corresponding to a
subpopulation of Dlx2-expressing cells as compared to Dlx2
whole-mount in situ hybridization (Figs. 2B,C). As devel-
opment progressed, expression appeared to bifurcate into
maxillary and mandibular expression domains (Fig. 2B,
inset). The other two lines did not show similar expression
at this early stage. Primary transgenic embryos (4/6) carry-
ing only the mI12a element within the reporter construct
(construct 3) were assessed and showed mandibular staining
similar to that obtained with the mI12a 1.9-kb construct
(Fig. 2D).
By E10.5–11, all lines of transgenic mice showed lacZ
expression in bilateral regions between the lateral and
medial portions in the first arch (Figs. 2E,F). Whole-mount
in situ hybridization, for Dlx2 transcripts, performed after
staining for h-galactosidase activity with X-Gal (Tajbakhsh
and Houzelstein, 1995), indicates that cells expressing the
transgene (Fig. 2F, arrowhead) correspond to a subpopula-
tion of the Dlx2-expressing cells in the most distal aspect of
the endogenous expression domain.
Transgenic mice were also produced with a similar
reporter construct containing a 1.6-kb XhoI–XhoI fragmentof the zebrafish dlx1/dlx2 intergenic region (Fig. 1B, con-
struct 5). The sequence similarity between the zebrafish and
the mouse genomic fragments used to make the transgene
described above is limited to the I12a enhancer. One stable
line of transgenic mice was obtained and analysis of the
embryos from this line resulted in patterns of transgene
expression identical to those obtained with the mouse
version of the I12a-lacZ transgene (Figs. 2G,H). We con-
clude that the zebrafish intergenic sequence, zI12a, is able to
target expression in mouse embryos in a way that is
identical to its mouse counterpart.
Sections indicate that the observed h-galactosidase-pos-
itive cells are mesenchymal and that there is no epithelial
expression (Figs. 2I, arrowheads, J). The existence of
specific interactions between intergenic elements and regu-
latory sequences located upstream of the Dlx promoters
might explain the incomplete expression of reporter trans-
genes containing I12a. Previous work has shown a lacZ
construct containing 3.8-kb 5V-flanking fragment of Dlx2
replicates endogenous expression in the epithelium but not
in the mesenchyme (Thomas et al., 2000). To determine
whether combining the I12a intergenic enhancer to the Dlx2
5V-flanking sequences would synergistically reproduce the
complete expression of Dlx2 in branchial arch mesenchymal
cells, we added the 1.9-kb XbaI–EcoRI mouse fragment
containing I12a to the Dlx2-lacZ construct previously used
by Thomas et al. (2000). The resulting transgene, Dlx2-
lacZ-I12a (Fig. 1A, construct 4) was expressed in transgenic
mice with patterns that represent the sum of the expression
of Dlx2-lacZ and I12a-lacZ; that is, the epithelial expression
of Dlx2-lacZ and the spatially-restricted mesenchymal ex-
pression of I12-lacZ (Figs. 2K,L). Thus, the inability of
I12a-lacZ to reconstitute the complete patterns of Dlx2
expression in the first arch mesenchyme is not due to the
lack of specific interactions or synergy between the cis-
acting regulatory sequences in the intergenic region (I12a)
and in the flanking (3.8 kb) region of Dlx2, but suggests the
existence of additional regulatory elements.
As development progresses, lacZ expression in I12a
transgenic mice is maintained in the mandible (Figs.
3A,B) and becomes apparent in bilateral domains of the
hyoid arch (Fig. 2A and data not shown). Transgene
expression remained exclusively mesenchymal and, by
E12.5, was restricted to the mesenchyme adjacent to the
epithelium in the tongue and mouth floor (Figs. 3C,D). At
E14.5, expression of the transgene was mainly observed in
the intraoral portion (Fig. 3E, arrow) and some part of the
external acoustic meatus (arrowhead). In the intraoral por-
tion, transgene expression became gradually restricted to
cells on the floor of the mouth with distinct distal limits that
extended to the areas of developing incisor teeth (Fig. 3F)
and to bilateral groups of cells on the lateral edges of the
tongue (Fig. 3G). At E14.5, transgene expression was also
observed in the dental papilla mesenchyme of the develop-
ing incisor teeth (Figs. 3H,I). Expression persisted in all
three lines of mice until at least E16.5 (data not shown).
Fig. 3. Expression of I12a-lacZ reporter transgene from E11.5. (A–D) Frontal sections at E11.5, and E12.5 reveals an overall loss of X-gal staining in the
mandible with a restriction of h-galactosidase activity to the mesenchyme abutting the oral epithelium as development progresses. The arrowhead and arrow in
(E) indicate transgene expression in the tongue and in the prospective middle ear, respectively. (F) View of the floor of the mouth. (G) Dissected tongue. (H, I)
Frontal sections at E14.5 show a targeting of transgene activity to the dental papilla. Embryonic stages are indicated. Original magnification: A, C, and H
(50), B, D, and I ( 400). DP, dental papilla; EM; ectomesenchyme; IDE, inner dental epithelium; OE, oral epithelium; T, tongue. Embryos shown are from
transgenic line 1483 (construct 2). Similar results were obtained with two additional lines produced with the same transgene (data not shown).
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the epithelium and is antagonistically regulated by FGF and
BMP4 signals
The extensive conservation of the I12a enhancer se-
quence of diverse vertebrates over more than 500 bp suggest
that it could be the site of interactions with multiple trans-
acting factors. To identify some of these factors, we per-formed experiments on mandibles dissected from the lines
of transgenic mice carrying the I12a-lacZ construct 2. It was
previously shown that expression of Dlx2 in the first
branchial arch is dependent on signals from the epithelium
(Thomas et al., 2000). Similarly, removal of epithelium at
E10.5 resulted in a loss of I12a-lacZ expression in the
mesenchyme (Figs. 4A,B). However, when the epithelium
was removed from the explants at E11.5, the expression of
B.K. Park et al. / Developmental Biology 268 (2004) 532–545538I12a-lacZ was not affected (data not shown). Therefore, the
activity of the I12a enhancer in the mesenchyme is tran-
siently dependent upon factors that originate from the
epithelium.
Fgf8 is expressed in patches of proximal oral epithelium
of the first arch overlying the Dlx mesenchymal expression
domain (Grigoriou et al., 1998; Tucker et al., 1999). FGF8
was shown to induce Dlx2 expression in the ectomesen-
chyme but to repress its expression in the epithelium
(Thomas et al., 2000). We therefore tested the ability of
FGF8 to induce I12a-lacZ expression in the mandibular
mesenchyme. Beads soaked in FGF8 were placed at various
positions in mandibles dissected at E9.5, and transgene
expression was determined by X-Gal staining 24 h later
(Fig. 4C). FGF8 induced transgene expression in a restricted
area around the bead that corresponds to the normal domain
of transgene expression (Fig. 4A), whereas BSA-soaked
control beads placed on the contralateral side had no effect
(Fig. 4C). The competence to express I12a-lacZ transgene
in response to an FGF signal is clearly restricted to the
normal pattern of expression, as beads implanted in a more
distal position (Fig. 4C, arrowhead) were not able to induce
transgene expression.
In contrast to the effects of FGF8, BMP4 did not induce
I12a-lacZ transgene expression but rather antagonized the
effects of FGF8 (Fig. 4D). Furthermore, BMP4-soaked
beads implanted in a mandible with the epithelium left
intact also caused decreases in I12a-lacZ transgene expres-
sion (data not shown). Thus, BMP4 has an overall negative
influence on the expression of the transgene. It was previ-Fig. 4. Regulation of I12-lacZ mandible expression by epithelial factors. LacZ tra
without the epithelium and manipulated with beads impregnated with the indic
presence of the oral epithelium at E10.5. (C) Transgene expression is activated onl
epithelium had been removed (-epi). A FGF8 bead (arrowhead) placed outside t
neighboring cells. BSA control (blue bead; right) has no effect on transgene expr
BMP4 signaling (blue bead; right). (E) Transgene expression is increased in man
soaked in Noggin (blue bead encircled), a BMP4 antagonist, compared to the co
within its normal domain (white beads circled) but is not inducible outside the typ
and oral side facing.ously shown that BMP4 was unable to induce Dlx2 expres-
sion in the mesenchyme when beads were implanted at
E10.5 (Thomas et al., 2000) contrary to a previous report
that BMP4 can induce Dlx2 expression in the first arch
mesenchyme at later stages of development (Bei and Maas,
1998). The influence of endogenous BMP4 signaling on the
I12a-lacZ transgene expression was further examined with
the use of Noggin beads cultured with dissected arches (Fig.
4E). Noggin’s ability to bind and inhibit BMP4 signaling
revealed an enrichment of the I12a-lacZ transgene expres-
sion compared to the contralateral control side; however, the
expanded expression beyond the initial subset of cells was
variable.
Other FGF family members are also expressed in the oral
epithelium of the mandibular arch and considered to have
redundant functions (Kettunen and Thesleff, 1998). To
determine if the I12a-lacZ transgene is similarly regulated
by other FGFs, FGF9-soaked beads were implanted into
dissected arches and cultured with or without the epithelium
(Fig. 4F and data not shown). Similar to FGF8, FGF9
strongly induced our transgene in the subset of cells.
However, as with FGF8, FGF9 was incapable of expanding
the expression domain (arrowhead, beads encircled).
Activity of the mouse I56i enhancer in the branchial arches
is distinct from that of I12a
We had previously observed that the I56i intergenic
enhancer is proficient in targeting transgene expression to
the forebrain domain of Dlx expression in both zebrafishnsgene expression was analyzed using cultured mandibular arches with and
ated proteins. (A, B) I12a-lacZ transgene expression is dependent on the
y in its normal domain by FGF8 (white beads) in mandibles from which the
he normal site of transgene expression does not induce lacZ expression in
ession. (D) Transgene activation by FGF8 (white beads) is antagonized by
dible mesenchyme with epithelium intact following implantation of a bead
ntralateral side. (F) Transgene expression is activated by FGF9 soak bead
ical region (arrowhead). Dissected mandibles are orientated distal to the top
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from mouse, but not its zebrafish counterpart, is also
capable of targeting transgene expression to the branchial
arches (Zerucha et al., 2000). We examined this activity in
greater detail in two of the three stable lines that carry the
mouse I56i-lacZ transgene (Fig. 5). Cells in the first
branchial arch first express the I56i-lacZ transgene at around
E9.25 (Figs. 5A,B), persisting at least until late in embry-
onic life (data not shown). By E10, cells from all branchial
arches express I56i-lacZ (Fig. 5C). Expression of the I56i-
lacZ transgene recapitulated the entire patterns of Dlx5
expression in the mandibular component of the first bran-
chial arch (Fig. 5D). At later stages, expression of the
reporter transgene was also observed in the maxillary
component of the first arch as previously observed in mice
with targeted integration of the lacZ within the Dlx5/Dlx6
locus (Acampora et al., 1999; Merlo et al., 2000; Robledo et
al., 2002). Similar to I12a, the I56i enhancer targeted
expression exclusively to the mesenchyme (Fig. 5F).
The I56i-lacZ transgene is regulated by FGFs and BMPs
To determine whether I56i-lacZ transgene expression is
modulated by signals from the epithelium comparable to
those that modulate I12a-lacZ, we performed mandible
explants and bead implantation experiments as those de-
scribed in Fig. 4. Mandibles that were dissected at E9.5 and
from which the epithelium was removed did not show
transgene expression following 18 h in culture (Figs.
6A,B). When the epithelium was removed at E10.5, trans-
gene expression was considerably reduced but not abolishedFig. 5. Expression of the I56i-lacZ transgene during embryogenesis. (A, B) h-galac
of the mandible. E10 embryos (C) show expression in the mandibular portion of t
forebrain (arrows). (D, F) By E11.5, arch expression includes distinct regions of th
Dissected mandibles (E9.5 and E11.5, respectively) show progressive expansion o
the level of the first arch with the maxillary division (Mx) on the top and the
expression in the epithelium (arrowhead). Embryonic stage is indicated. Embryos
(A, C, E) lateral views, (F) frontal view. Dissected mandibles (B, D) are orientat(Fig. 6C). In mandibles with the epithelium left intact,
implantation of a bead soaked in BMP4 resulted in
decreases in transgene expression around the bead com-
pared to the contralateral side. Similar effects were observed
when the experiment was performed at E9.5 (Fig. 6D, blue
bead encircled) and at E10.5 (Fig. 6E). In contrast, a bead
soaked in FGF8 produced increases in I56i-lacZ transgene
expression (Fig. 6F, right) but not as markedly as for the
I12a-lacZ transgene (Fig. 4C). Implantation of a BMP4
(blue) bead close to the FGF8 (white) bead abolished the
effects of FGF8 (Fig. 6F, left). As well, similar to the subset
of cells expressing I12a-lacZ, FGF8 beads cultured medi-
ally, outside the normal expression domain, were not capa-
ble of extending the patterns of reporter gene expression
(Fig 6G, arrowhead). Experiments carried out with beads
soaked in FGF9 (encircled) were able to induce I56i-lacZ
expression in the absence of epithelium in a similar manner
to FGF8 compared to control BSA (blue) beads on the
contralateral side (Fig. 6H).
Regulation of the I56i-LacZ expression domain by
endothelin-1 signaling
The endothelin signaling pathway has been implicated
in regulating Dlx6 expression in the most distal aspect of
the mandible (Charite et al., 2001). Mice deficient in
endothelin-1 (ET-1) (Kurihara et al., 1994) or in the
endothelin receptor A (EdnrA) (Clouthier et al., 2000)
results in a similar phenotype that includes retarded and
smaller mandibles. Further characterization of the EdnrA
mutant revealed an absence of Dlx6 expression in the mosttosidase activity is first observed at approximately E9.25 in the distal portion
he 1st branchial arch (star) and more caudal arches (arrowheads) and in the
e maxilla. (E) E12.5, transgene expression surrounds the oral cavity. (B, D)
f mandibular mesenchymal lacZ transgene expression. (F) Frontal section at
mandibular (Mn) division at the bottom reveals the absence of transgene
are from transgenic line 7098. Similar results were obtained with line 7089.
ed with distal to the top.
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expression. We investigated the influence of ET-1 signal-
ing on the I56i-lacZ transgene. Dissected mandibular
arches were cultured with an ET-1 antagonist, bosentan
(Clozel et al., 1994). Previous work has shown that
inhibition of ET-1 function in chick embryos with bosentan
(Actelion Pharmaceuticals Ltd.) results in a phenotype
similar to that of the ET-1 and EdnrA null mutants in
the mouse (Kempf et al., 1998). When I56i-lacZ dissectedFig. 6. Regulation of I56i-lacZ expression by epithelial factors and signaling molec
epithelium was dissected (B) or left intact (A) and transgene expression was determ
expression at E10.5 but not as striking as at E9.5 (B). (D) Implantation of a BMP
the epithelium left intact. (E) BMP4 is also able to impair transgene expression to a
induces or maintains I56i-lacZ expression in dissected mandibles from which the e
(blue bead, left) on the contralateral side. (G) Expression of the I56i-lacZ transgene
of transgene expression have no effect on the surrounding cells (arrowhead). (H)
receptive to FGF9-soaked beads (white) as compared to BSA (blue) beads on the o
panels G and H were stained for different times. Therefore, effects of FGF beads sh
arches are orientated distal to the top and oral side facing.arches were treated with bosentan, a loss of lacZ expres-
sion was observed in the most distal aspect of the
expression domain (Fig. 7B), compared to controls (Fig.
7A), yet still maintained proximal lacZ expression. The
loss of distal lacZ expression by ET-1 inhibition is similar
to the loss of endogenous Dlx6 expression previously
reported by Clouthier et al. (1998) in mice deficient for
EdrA and its effects on spatial distribution of Dlx5 tran-
scripts (Figs. 7C,D). When bosentan was tested on I12a-ules. (A, B) Mandibles were dissected from transgenic embryos at E9.5. The
ined 18 h later. (C) Removal of the epithelium causes decreases in I56i-lacZ
4 bead (encircled) impairs I56i-lacZ expression in dissected mandibles with
lesser degree in older E10.5 mandibles. (F) Presence of a FGF8 white bead
pithelium was removed (right); however, this effect is antagonized by BMP4
is increased by FGF8 activity, but beads placed outside the normal domain
In a similar manner to FGF8, transgene activity in the mesenchyme is also
pposite side in arches with the epithelium removed. The mandibles shown in
ould be individually compared with the contralateral control side. Dissected
Fig. 7. Differential impact of inhibition of ET-1 signaling on I56i and I12a enhancer activity. Dissected mandibular arches (E10.5) cultured in serum (A, C, E,
G) are compared with arches cultured with medium containing the ET-1 inhibitor bosentan (B, D, F, H). Arches are shown from the oral aspect with ventral to
the top. I56i arches cultured with bosentan and stained with X-gal show loss of distal expression of the transgene (A, B). Whole-mount in situ hybridization
with a Dlx5 riboprobe shows similar loss of distal expression (C, D). Bosentan has no effect on I12a activity in dissected mandibles (E, F), nor does it affect
spatial Dlx2 expression (G, H). Arrowheads indicate distal limit of the expression domain.
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spatial patterns of Dlx2 expression were not affected (Figs.
7G,H). The overall levels of Dlx2 and Dlx5 transcripts as
estimated by the intensity of the hybridization signals,
appeared to be reduced by bosentan (Figs. 7C,D,G,H).Discussion
Distinct enhancers target expression of the Dlx1/Dlx2 and
of the Dlx5/Dlx6 genes to the mesenchyme of the branchial
arches
The overlapping expression of Dlx homeobox genes in
the branchial arches of vertebrates and the phenotype of
mutations affecting these genes suggest common regulatory
mechanisms and partial functional redundancy. Functional
analysis of the Dlx1/Dlx2 and Dlx5/Dlx6 bigene clusters
suggest that their functional specificity in craniofacial de-
velopment might be related to the spatial and temporal
control of their expression.The six Dlx genes found in most vertebrates are orga-
nized as three bigene clusters, Dlx1/2, Dlx3/4 (formerly
Dlx3/7), and Dlx5/6, in which the two genes are organized
in an inverted convergent configuration (Panganiban and
Rubenstein, 2002) and are separated by a short intergenic
region (Ellies et al., 1997; McGuinness et al., 1996;
Simeone et al., 1994; Stock et al., 1996). Highly conserved
sequences were found in the intergenic regions of all three
bigene clusters (Ghanem et al., 2003; Sumiyama and
Ruddle, 2003; Sumiyama et al., 2002; Zerucha et al.,
2000). Enhancer activity has been demonstrated for some
of these sequences. Thus, the I56i and I56ii from the Dlx5/6
locus and I12b from the Dlx1/Dlx2 locus act as a forebrain
enhancer that largely or completely recapitulates expression
of the flanking genes in this tissue (Ghanem et al., 2003;
Zerucha et al., 2000).
We also found that two conserved intergenic sequences,
I56i and I12a, can target expression of reporter transgenes to
the branchial arch mesenchyme of transgenic mice, albeit
with distinct patterns. I56i-lacZ was initially expressed in
the distal aspect of the first arch and extended into all the
B.K. Park et al. / Developmental Biology 268 (2004) 532–545542pharyngeal arches and, later in development, into the
maxilla. Thus, the mouse I56i enhancer targeted transgene
expression to the branchial arches with patterns similar to
the endogenous Dlx5/6 expression (Fig. 4) from E9.25 until
at least late embryonic life.
In contrast to I56i-lacZ, which was expressed in the
entire mesenchymal domain of Dlx5 expression, only cells
in the most distal part of the mouse Dlx2 expression domain
in the mandibular component of the first branchial arch
expressed I12a-lacZ reporter transgenes (Figs. 1 and 2, and
data not shown). Similar transgene expression was observed
in six independent lines containing the entire mouse Dlx1/
Dlx2 intergenic sequence, in three lines containing a 1.9-kb
fragment encompassing the I12a conserved element, and in
4/6 primary transgenic embryos containing only the I12a
sequence (Figs. 1 and 2). Transgene expression in the
tongue and in the floor of the mouth at later stages of
development (Fig. 3) was reminiscent of endogenous Dlx2
expression. However, only weak expression of the transgene
was observed in the developing incisors and molars through
these developmental stages and we cannot exclude that
additional cis-acting regulatory elements involved odonto-
genic regulation of Dlx1/Dlx2 are located elsewhere.
The inability of I12a to reconstitute the entire Dlx
expression pattern in the mesenchyme of the first arch is,
at present, unclear. It is surprising that the mesenchyme
expression of Dlx2 is not regulated as a whole (as seen for
Dlx5 via I56i), but through the action of enhancers such as
I12a that regulate Dlx2 expression only in a subset of cells.
The most likely explanation at this time is that additional
regulatory sequences, necessary to recapitulate the complete
Dlx1/Dlx2 expression in the arch mesenchyme, are located
elsewhere in the Dlx1/Dlx2 locus, outside the intergenic
region and the first 3.8 kb of Dlx2 5V-flanking sequence
(Thomas et al., 2000). Such additional cis-acting sequences
might act in coordination with I12a to induce mesenchymal
expression of Dlx1/Dlx2. Alternatively, the two cis-acting
regulatory elements might target independently two distinct
groups of mesenchymal cells.
Mesenchymal expression in the maxilla was only ob-
served in one of the lines of transgenic animals (line 1486).
Temporal analysis of lacZ expression in animals of this line
indicates that the mandibular and maxillary components of
the transgene expression domain may result from the
separation of a group of expression cells that is initially
contiguous (Fig. 1D, and data not shown). The presence of
such transgene expression patterns in only one line of
transgenic animals is at present unclear. It is unlikely to
be due to the coincidental insertion of the transgene near a
tissue-specific enhancer with similar activity as transgene
expression persists until it results in the same mesenchymal
expression as for the other lines (Fig. 1). The intensity of h-
galactosidase staining in the mandibular mesenchyme of
line 1486 was less than in the other transgenic lines,
indicating that increased transgene copy number or integra-
tion in a chromosomal region more favorable for transcrip-tional activity are unlikely explanations for our observation.
The lower ability of I12a to target expression of the reporter
transgene to the maxillary component of the first arch is
suggestive of distinct regulatory mechanisms for the man-
dibular and maxillary components, something that was
already suggested by the differential expression of Dlx5
and Dlx6 in the mandibular and maxillary components of
the first arch.
The I12a enhancer sequence is 99% identical between
mouse and human and more than 90% identical between
mammals and teleost fish (Ghanem et al., 2003), a degree of
conservation that surpasses that found in the coding region
of the Dlx genes. We found comparable percentages of
conservation between I56i sequences of the same vertebrate
species. However, I12a and I56i do not show any striking
sequence similarity despite the partial overlap in their
branchial arch activity. We had also found that the various
forebrain enhancers, I56i, I56ii and I12b, did not show
much similarity in their sequence despite a highly over-
lapping activity (Ghanem et al., 2003). In fact, the similarity
in sequence between I56i and I12b was limited to a short
region that contains two potential binding sites for DLX
homeodomain proteins, consistent for a role in a Dlx cross-
regulatory or autoregulatory mechanisms involving at least
the I56i enhancer (Zerucha et al., 2000).
The mouse I56i sequence was able to target expression to
the arches, but the orthologous zebrafish I56i (I46i) could
not (Zerucha et al., 2000), suggesting regulatory evolution-
ary divergence among conserved sequences. This is surpris-
ing considering the two sequences are 81% identical. We
have ruled out that this difference could be due to orienta-
tion of the sequence of the enhancer within the transgene
(Zerucha et al., 2000). Therefore, it appears that even small
differences in sequence could influence branchial arch
expression. Such small differences could be used to identify
essential protein binding sites within I56i.
Recently, a 245-bp enhancer, I37-2 in the Dlx3/Dlx4
(formerly Dlx3/Dlx7) intergenic region was shown to target
mesenchymal arch expression in a pattern that overlaps with
that of I56i but is, overall, distinct (Sumiyama and Ruddle,
2003). Interestingly, I37-2 and I56i both contain a pair of
putative DLX binding sites showing similarity in their
arrangements. This arrangement may be essential for auto-
or cross-regulatory mechanisms that involve DLX proteins
(Zerucha et al., 2000).
Role of epithelial and mesenchymal factors in enhancer
activity
Expression of Dlx2 in the first branchial arch is depen-
dent on signals, such as BMP4 and FGF8. FGF8 was shown
to induce Dlx2 expression in the ectomesenchyme but to
repress its expression in the epithelium where Dlx2 was
induced by BMP4 (Thesleff and Sharpe, 1997; Thomas et
al., 2000). Similarly, the early I12a-lacZ transgene expres-
sion was reliant on signals from the epithelium because
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transgene expression in the mesenchyme, but when the
epithelium was removed at E11.5, transgene expression
was not affected. FGF8 induced the I12a-lacZ transgene
expression, although the competence to express transgene in
response to FGF8 was clearly restricted to the same sub-
population of Dlx2-expressing ectomesenchyme observed in
intact I12a-lacZ transgenic animals. Thus, the restricted
I12a enhancer activity is unlikely to be the result of its
isolation from additional regulatory sequences, as postulated
above, resulting in an overall lower responsiveness to FGF.
We cannot rule out at this time that the effects of FGFs on
transgene expression are indirect and are not the reflection
of changes in either the integrity or specification status of
the tissue. Other FGF family members are expressed in the
oral epithelium. One member, expressed slightly after FGF8
yet before tooth development in the epithelium is FGF9
(Tucker et al., 1999). Repetition of our experiments implant-
ing beads imbued with FGF9 resulted in similar induction of
the transgene as observed for FGF8.
FGFs and BMP4 are known to regulate endogenous Dlx2
expression and act to restrict expression to the proximal
mesenchyme. The effects of FGFs and BMP4 on I12a-lacZ
expression suggest that this I12a is at least partly involved in
this regulation. In contrast to the positive effects of FGF8
and FGF9 signaling, BMP4 exhibited overall negative
influences on the expression of the I12a-lacZ transgene
within the mandibular arch. Increased transgene expression
resulting from implantation of Noggin-coated beads, an
inhibitor of BMP4 function, further supported a negative
influence for BMP4 (Tucker et al., 1998a).
I56i-lacZ expression was also modulated by FGF8,
FGF9, and BMP4 cues emanating from the epithelium.
The results presented here suggest that the effects of FGF
and BMP signaling on the expression of at least two Dlx
bigene clusters, Dlx1/2 and Dlx5/6, in the mesenchyme of
the first branchial arch may be mediated through the action
of these signaling pathways on intergenic enhancers.
The endothelin-1 (ET-1) signaling pathway has previ-
ously been shown to affect Dlx gene expression in the
arches of both zebrafish and mice. The zebrafish ET-1
mutant, sucker, disrupts ventral arch development and
exhibits a loss of dlx3a expression (Miller et al., 2000).
Loss of function of the endothelin-A receptor (EdnrA) in
mice reveals its necessity for Dlx3 expression in the arches
and for maintaining Dlx2 expression in the hyoid arch
(Clouthier et al., 2000). Distal expression of Dlx6 has been
shown to be dependant on ET-1 signaling and is lost in
EdnrA-deficient mice (Charite et al., 2001). Here, the
expression of the I56i-lacZ transgene was shown to be
ET-1-dependant, especially in its distal domain (Fig. 7).
Thus, the I56i enhancer may be involved in mediating the
effects of ET-1. Recently, Yanagisawa et al. (2003) showed
that a genetic loss of an arch-specific enhancer of dHAND, a
transcription factor also downstream of ET-1 signaling and
influenced by DLX6, results in a loss of ventrolateralexpression yet retains its distal (ventral) tip expression.
The arch enhancer mutant mice exhibit severely truncated
Meckel’s cartilage but nonetheless form the distal primordia.
In contrast to its effects on I56i and Dlx6, Bosentan did not
impair I12a enhancer activity or spatial expression of Dlx2
in the mandibular arch at E10.5. This result is consistent
with the changes in Dlx2 expression in the EdnrA(/) mice,
which are observed specifically in the hyoid at E10.5 with
no visible changes in mandibular expression of Dlx2
(Clouthier et al., 2000). The overall levels of Dlx2 and
Dlx5 transcripts were reduced after bosentan treatments,
which is consistent with a prior suggestion that ET-1 may be
involved in maintenance of Dlx expression (Figs. 7G,H, and
Tucker et al., 1999). Thus, activity of the I56i and I12a
enhancers reflects the specific effects of ET-1 signaling on
Dlx paralogs in the mandibular arch.
Advanced morphological innovations, such as the mod-
ern vertebrate jaw, have been correlated with changes in
gene activity within multigene families (Neidert et al.,
2001). It has been suggested that the nested Dlx expression
pattern assisted in the evolution of the jaw (Beverdam et al.,
2002; Depew et al., 2002), a gnathosome innovation, since
jawless vertebrates, such as lampreys, do not exhibit nested
Dlx expression in the pharyngeal arches (Neidert et al.,
2001). Alterations of the Dlx gene expression patterns likely
arose due to evolutionary changes in the regulatory elements
(Quint et al., 2000) in addition to a proposed heterotypic
shift of epitheliomesenchymal interactions (Shigetani et al.,
2002) that likely facilitated the restricted expression patterns
responsible for the proximodistal patterning of the mandib-
ular arch.
Heterodont mammals have distinct types of dentitions
arising from different positions around the presumptive jaw.
It was previously suggested that the determination of where
and what kind of teeth develop arises as the result of the
overlapping expression patterns of antagonistic FGF and
BMP signaling factors and regionalization of different
transcription factor expression patterns in the mandibular
and maxillary arches; supported by the Dlx bigene loss-of-
function phenotypes outlined in a odontogenic homeodo-
main code that specifies tooth patterning (Sharpe, 1995).
FGF8 and BMP4 have been shown to be involved in the
spatial patterning of Dlx2 expression (Thomas et al., 2000)
as well as Barx1 (Tucker et al., 1998a), Pax9 (Neubuser et
al., 1997), and Lhx (Grigoriou et al., 1998) and Msx1
(Ferguson et al., 2000) homeodomain genes. Understanding
how the odontogenic process is established requires under-
standing of the various factors that establish the expression
patterns of regulatory genes such as the Dlx. We identified
regulatory elements that contribute to Dlx expression in the
mandibular arch mesenchyme and factors that contribute to
their activity. The possibility of a specific subset of cells
being subjected to differential regulation within the arch
mesenchyme suggests an additional level of complexity in
the patterning of the permissive tissue in interpreting the
multiple signaling cues from the surrounding epithelium.
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